A Randomized, Double-Blind Placebo-Controlled, Multi-Centric Clinical Trial of Ultra-diluted Mycobacterium tuberculosis Nosode (Emtact 30C) in the Management of Recurrent Upper and Lower Respiratory Tract Affections